Johnson & Johnson/$JNJ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Ticker
$JNJ
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
138,100
ISIN
US4781601046
Website
JNJ Metrics
BasicAdvanced
$370B
17.09
$8.98
0.48
$4.96
3.39%
Price and volume
Market cap
$370B
Beta
0.48
52-week high
$169.99
52-week low
$140.68
Average daily volume
7.9M
Dividend rate
$4.96
Financial strength
Current ratio
1.257
Quick ratio
0.963
Long term debt to equity
49.104
Total debt to equity
52.922
Dividend payout ratio (TTM)
54.76%
Interest coverage (TTM)
30.08%
Management effectiveness
Return on assets (TTM)
7.77%
Return on equity (TTM)
29.45%
Valuation
Price to earnings (TTM)
17.093
Price to revenue (TTM)
4.138
Price to book
4.73
Price to tangible book (TTM)
-118.64
Price to free cash flow (TTM)
19.903
Dividend yield (TTM)
3.23%
Forward dividend yield
3.39%
Growth
Revenue change (TTM)
4.30%
Earnings per share change (TTM)
-41.22%
3-year revenue growth (CAGR)
-1.99%
3-year earnings per share growth (CAGR)
6.59%
3-year dividend per share growth (CAGR)
5.37%
What the Analysts think about JNJ
Analyst ratings (Buy, Hold, Sell) for Johnson & Johnson stock.
JNJ Financial Performance
Revenues and expenses
JNJ Earnings Performance
Company profitability
JNJ News
AllArticlesVideos
Johnson & Johnson: Relative Stability In A Wild 2025 Stock Market
Seeking Alpha·4 hours ago
J&J CEO Joaquin Duato on cancer treatments, M&A outlook and 'most favored nation' policy
CNBC Television·6 hours ago
These 2 Dividend Stocks Have Grown Dividends For 50 Consecutive Years. Can That Streak Continue?
24/7 Wall Street·7 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jun10
Johnson & Johnson
Dividend·Payment
$1.30Per share
FAQs
What’s the current market cap for Johnson & Johnson stock?
Johnson & Johnson (JNJ) has a market cap of $370B as of May 30, 2025.
What is the P/E ratio for Johnson & Johnson stock?
The price to earnings (P/E) ratio for Johnson & Johnson (JNJ) stock is 17.09 as of May 30, 2025.
Does Johnson & Johnson stock pay dividends?
Yes, the Johnson & Johnson (JNJ) stock pays dividends to shareholders. As of May 30, 2025, the dividend rate is $4.96 and the yield is 3.39%. Johnson & Johnson has a payout ratio of 54.76% on a trailing twelve-month basis.
When is the next Johnson & Johnson dividend payment date?
The next Johnson & Johnson (JNJ) dividend payment is scheduled for June 10, 2025.
What is the beta indicator for Johnson & Johnson?
Johnson & Johnson (JNJ) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.